Please ensure Javascript is enabled for purposes of website accessibility

Why Asensus Surgical Stock Is Soaring Today

By Keith Speights - May 26, 2021 at 12:04PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

An analyst initiated a buy recommendation for the surgical-robot company.

What happened

Shares of Asensus Surgical (ASXC -0.36%) were soaring 27.1% as of 11:36 a.m. EDT on Wednesday. The big jump came after H.C. Wainwright analysts initiated coverage on the stock with a buy rating. The analysts set a price target of $4 per share.

So what

It's not a great idea to base an opinion on a stock solely because of an analyst's recommendation. But investors can profit from understanding why an analyst is bullish about a stock.

Robotic surgical system

Image source: Getty Images.

In this case, H.C. Wainwright is very optimistic about Asensus Surgical's prospects. The price target reflects a premium of 97% above the Tuesday closing price for the healthcare stock. This positive recommendation for Asensus comes about two weeks after the company provided an encouraging first-quarter update. 

CEO Anthony Fernando said that the company saw "signs of recovery" from the pandemic in the first quarter. The company signed two lease agreements with hospitals for its Senhance robotic surgical system. It also received an expanded 510(k) clearance from the Food and Drug Administration for the general surgical indication for Senhance.

Now what

Asensus expects continued momentum this year. The company projects that it will install as many as 12 new Senhance systems by the end of 2021, including two in the second quarter. Asensus also plans to file for 510(k) clearance with the FDA in the second quarter for the next wave of its Intelligent Surgical Unit features.

Keith Speights has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Asensus Surgical, Inc. Stock Quote
Asensus Surgical, Inc.
ASXC
$0.56 (-0.36%) $0.00

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
377%
 
S&P 500 Returns
123%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/09/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.